120 related articles for article (PubMed ID: 779134)
1. [Cholestyramine as a cholesterol lowering preparation. A clinical evaluation].
Bye A; Brox D
Tidsskr Nor Laegeforen; 1976 Jun; 96(16):928-9. PubMed ID: 779134
[No Abstract] [Full Text] [Related]
2. The efficacy of lipid lowering drugs alone and in combination.
Hansen PF
Postgrad Med J; 1975; 51(8):63-5. PubMed ID: 768949
[No Abstract] [Full Text] [Related]
3. [Clinical trials of cholestyramine alone and in combination with clofibrate in hypercholesterolemia].
Carlson LA; Olsson AG; Orö L; Rössner S
Lakartidningen; 1974 Sep; 71(36):3289-91. PubMed ID: 4605566
[No Abstract] [Full Text] [Related]
4. Type IIa hyperlipoproteinaemia. An evaluation of four therapeutic regimens.
Watermeyer GS; Mann JI; Truswell AS; Levy I
S Afr Med J; 1975 Apr; 49(15):631-4. PubMed ID: 1094562
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein lipid alterations with cholestyramine administration.
Jones RJ; Dobrilovic L
J Lab Clin Med; 1970 Jun; 75(6):953-66. PubMed ID: 5421080
[No Abstract] [Full Text] [Related]
6. [Hypolipidemic effect of cholestyramine in patients affected by type II hyperlipoproteinemia].
Sauvanet JP; Drouin P; Mejean L; Lambert D; Debry G
Therapie; 1978; 33(5):615-22. PubMed ID: 217121
[No Abstract] [Full Text] [Related]
7. Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
Krüger B
Int J Clin Pharmacol Res; 1994; 14(5-6):177-83. PubMed ID: 7672874
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and compliance with cholestyramine bar versus powder in the treatment of hyperlipidemia.
Sweeney ME; Fletcher BJ; Rice CR; Berra KA; Rudd CM; Fletcher GF; Superko RS
Am J Med; 1991 Apr; 90(4):469-73. PubMed ID: 2012087
[TBL] [Abstract][Full Text] [Related]
9. Response of hyperlipoproteinemia to cholestyramine resin.
Fallon HJ; Woods JW
JAMA; 1968 Jun; 204(13):1161-4. PubMed ID: 5694692
[No Abstract] [Full Text] [Related]
10. Essential hyperlipemia with xanthomatosis: effects of cholestyramine and clofibrate.
Roe DA
Arch Dermatol; 1968 Apr; 97(4):436-45. PubMed ID: 5643239
[No Abstract] [Full Text] [Related]
11. Cholestyramine for elevated serum cholesterol.
Med Lett Drugs Ther; 1974 Apr; 16(8):33-4. PubMed ID: 4362570
[No Abstract] [Full Text] [Related]
12. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
Maíz A; Arteaga A; Villanueva CL; Velasco N; Acosta AM
Rev Med Chil; 1990 Sep; 118(9):1009-13. PubMed ID: 2152729
[TBL] [Abstract][Full Text] [Related]
13. Factorial study of the efficacy of cholestyramine, L-tryptophan and clofibrate in human nephrotic hyperlipidaemia.
Schapel GJ; Edwards KD; Neale FC
Prog Biochem Pharmacol; 1974; 9():82-98. PubMed ID: 4438384
[No Abstract] [Full Text] [Related]
14. Review of clinical studies of bile acid sequestrants for lowering plasma lipid levels.
LaRosa J
Cardiology; 1989; 76 Suppl 1():55-61; discussion 61-4. PubMed ID: 2653624
[TBL] [Abstract][Full Text] [Related]
15. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
Stein E; Kreisberg R; Miller V; Mantell G; Washington L; Shapiro DR
Arch Intern Med; 1990 Feb; 150(2):341-5. PubMed ID: 2405804
[TBL] [Abstract][Full Text] [Related]
16. The pediatrician's role in genetic hyperlipidemias.
Schleman MM
Del Med J; 1981 Sep; 53(9):473-4. PubMed ID: 7338289
[No Abstract] [Full Text] [Related]
17. [Effect of hexanicotinate of meso-inositol in patients with primary hyperlipidemia (author's transl)].
Agusti R; Jordán C; Aste H; Tapia F
Rev Invest Clin; 1978; 30(4):327-35. PubMed ID: 362498
[No Abstract] [Full Text] [Related]
18. Hyperlipidemia: reducing the chances of cardiovascular disease.
Nash DT
Geriatrics; 1984 Jul; 39(7):99-100, 103-4,108-9 passim. PubMed ID: 6588017
[No Abstract] [Full Text] [Related]
19. Cholestyramine in type II hyperlipoproteinemia. A double-blind trial.
Levy RI; Fredrickson DS; Stone NJ; Bilheimer DW; Brown WV; Glueck CJ; Gotto AM; Herbert PN; Kwiterovich PO; Langer T; LaRosa J; Lux SE; Rider AK; Shulman RS; Sloan HR
Ann Intern Med; 1973 Jul; 79(1):51-8. PubMed ID: 4578640
[No Abstract] [Full Text] [Related]
20. Effect of bezafibrate and colestyramine in patients with primary hypercholesterolemia.
Steinhagen-Thiessen E; Müller S; Holler HD; Lang PD
Arzneimittelforschung; 1987 Jun; 37(6):726-8. PubMed ID: 3311054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
